Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.70)
# 878
Out of 4,667 analysts
523
Total ratings
43.15%
Success rate
9.37%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRO Sutro Biopharma | Reiterates: Buy | $12 | $2.67 | +349.44% | 15 | Nov 18, 2024 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $20 | $3.13 | +538.98% | 15 | Nov 15, 2024 | |
| ACIU AC Immune | Reiterates: Buy | $16 | $3.24 | +393.83% | 13 | Nov 15, 2024 | |
| ANNX Annexon | Reiterates: Buy | $30 | $5.16 | +481.40% | 13 | Nov 15, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $15 | $4.12 | +264.08% | 11 | Nov 15, 2024 | |
| BPMC Blueprint Medicines | Reiterates: Buy | $135 | $94.81 | +42.39% | 16 | Nov 15, 2024 | |
| IMAB I-Mab | Reiterates: Buy | $8 | $0.98 | +716.33% | 12 | Nov 15, 2024 | |
| KMDA Kamada | Reiterates: Buy | $11 | $5.82 | +89.00% | 8 | Nov 14, 2024 | |
| LQDA Liquidia | Reiterates: Buy | $29 | $10.12 | +186.56% | 11 | Nov 14, 2024 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $2.31 | +895.67% | 12 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $2.99 | +33.78% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $6 | $3.13 | +91.69% | 11 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $14.40 | +483.33% | 13 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $14.26 | +54.28% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.37 | +532.91% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.99 | +83.39% | 7 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $1 | $0.29 | +244.83% | 16 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $21.15 | +41.84% | 12 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.05 | +457.38% | 11 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $5.23 | +129.45% | 17 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $3.67 | +172.48% | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $4.40 | +490.91% | 9 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $54.14 | +84.71% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $3.64 | +862.86% | 8 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $16.27 | +65.95% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $24.42 | +268.55% | 19 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $11.31 | +209.46% | 10 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $72.67 | +23.85% | 11 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $42.93 | +98.00% | 13 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $190 | $123.29 | +54.11% | 14 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $87 | $22.69 | +283.43% | 14 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $300 | $156.00 | +92.31% | 18 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $425 | $364.33 | +16.65% | 13 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $7 | $0.51 | +1,277.95% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $600 | $451.23 | +32.97% | 23 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $8.96 | +123.21% | 12 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $16.08 | +397.51% | 5 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $7.86 | +154.45% | 12 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.17 | +583.76% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.30 | +310.96% | 8 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $44.05 | +4.43% | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $4.05 | +72.84% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.62 | +77.94% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.80 | +1,328.57% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.54 | +27,677.78% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $0.49 | +506.80% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.76 | +215.13% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $3.01 | +1,228.90% | 3 | Mar 16, 2022 |
Sutro Biopharma
Nov 18, 2024
Reiterates: Buy
Price Target: $12
Current: $2.67
Upside: +349.44%
Zentalis Pharmaceuticals
Nov 15, 2024
Reiterates: Buy
Price Target: $20
Current: $3.13
Upside: +538.98%
AC Immune
Nov 15, 2024
Reiterates: Buy
Price Target: $16
Current: $3.24
Upside: +393.83%
Annexon
Nov 15, 2024
Reiterates: Buy
Price Target: $30
Current: $5.16
Upside: +481.40%
TScan Therapeutics
Nov 15, 2024
Reiterates: Buy
Price Target: $15
Current: $4.12
Upside: +264.08%
Blueprint Medicines
Nov 15, 2024
Reiterates: Buy
Price Target: $135
Current: $94.81
Upside: +42.39%
I-Mab
Nov 15, 2024
Reiterates: Buy
Price Target: $8
Current: $0.98
Upside: +716.33%
Kamada
Nov 14, 2024
Reiterates: Buy
Price Target: $11
Current: $5.82
Upside: +89.00%
Liquidia
Nov 14, 2024
Reiterates: Buy
Price Target: $29
Current: $10.12
Upside: +186.56%
Protara Therapeutics
Nov 14, 2024
Reiterates: Buy
Price Target: $23
Current: $2.31
Upside: +895.67%
Nov 14, 2024
Reiterates: Neutral
Price Target: $4
Current: $2.99
Upside: +33.78%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $3.13
Upside: +91.69%
Nov 13, 2024
Reiterates: Buy
Price Target: $84
Current: $14.40
Upside: +483.33%
Nov 13, 2024
Reiterates: Buy
Price Target: $22
Current: $14.26
Upside: +54.28%
Nov 13, 2024
Reiterates: Buy
Price Target: $15
Current: $2.37
Upside: +532.91%
Nov 13, 2024
Reiterates: Buy
Price Target: $55
Current: $29.99
Upside: +83.39%
Nov 13, 2024
Downgrades: Neutral
Price Target: $6 → $1
Current: $0.29
Upside: +244.83%
Nov 8, 2024
Reiterates: Buy
Price Target: $30
Current: $21.15
Upside: +41.84%
Nov 8, 2024
Reiterates: Buy
Price Target: $17
Current: $3.05
Upside: +457.38%
Nov 8, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $5.23
Upside: +129.45%
Nov 8, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $3.67
Upside: +172.48%
Nov 8, 2024
Reiterates: Buy
Price Target: $26
Current: $4.40
Upside: +490.91%
Nov 7, 2024
Reiterates: Buy
Price Target: $100
Current: $54.14
Upside: +84.71%
Nov 7, 2024
Reiterates: Buy
Price Target: $35
Current: $3.64
Upside: +862.86%
Nov 7, 2024
Reiterates: Buy
Price Target: $27
Current: $16.27
Upside: +65.95%
Nov 7, 2024
Reiterates: Buy
Price Target: $90
Current: $24.42
Upside: +268.55%
Nov 6, 2024
Reiterates: Buy
Price Target: $35
Current: $11.31
Upside: +209.46%
Nov 1, 2024
Reiterates: Buy
Price Target: $90
Current: $72.67
Upside: +23.85%
Nov 1, 2024
Reiterates: Buy
Price Target: $85
Current: $42.93
Upside: +98.00%
Nov 1, 2024
Reiterates: Buy
Price Target: $190
Current: $123.29
Upside: +54.11%
Oct 31, 2024
Reiterates: Buy
Price Target: $87
Current: $22.69
Upside: +283.43%
Oct 31, 2024
Reiterates: Buy
Price Target: $300
Current: $156.00
Upside: +92.31%
Oct 31, 2024
Maintains: Buy
Price Target: $400 → $425
Current: $364.33
Upside: +16.65%
Oct 24, 2024
Maintains: Buy
Price Target: $5 → $7
Current: $0.51
Upside: +1,277.95%
Oct 21, 2024
Reiterates: Buy
Price Target: $600
Current: $451.23
Upside: +32.97%
Oct 7, 2024
Reiterates: Buy
Price Target: $20
Current: $8.96
Upside: +123.21%
Sep 23, 2024
Reiterates: Buy
Price Target: $80
Current: $16.08
Upside: +397.51%
Aug 12, 2024
Reiterates: Buy
Price Target: $20
Current: $7.86
Upside: +154.45%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $1.17
Upside: +583.76%
Aug 6, 2024
Reiterates: Buy
Price Target: $30
Current: $7.30
Upside: +310.96%
Jun 17, 2024
Reiterates: Buy
Price Target: $46
Current: $44.05
Upside: +4.43%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $4.05
Upside: +72.84%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.62
Upside: +77.94%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.80
Upside: +1,328.57%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.54
Upside: +27,677.78%
May 5, 2022
Downgrades: Neutral
Price Target: $10 → $3
Current: $0.49
Upside: +506.80%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.76
Upside: +215.13%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $3.01
Upside: +1,228.90%